Impact Biotech
About
ImPact Biotech is focused on the development and launch of Padeliporfin VTP (Vascular Targeted Photodynamic) therapy for the treatment of solid tumors. The company is headquartered in Israel, with presence in Luxembourg, France and USA, as well as its own GMP-certified (Good Manufacturing Practice) manufacturing capabilities.
Technology stack
detected 2026-06-30Email
Microsoft 365
Hosting
self_managed
Stack
jQuery
WordPress
Analytics
Google Analytics 4
SEO
Rank Math
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Impact Biotech do?
ImPact Biotech is focused on the development and launch of Padeliporfin VTP (Vascular Targeted Photodynamic) therapy for the treatment of solid tumors. The company is headquartered in Israel, with presence in Luxembourg, France and USA, as well as its own GMP-certified (Good Manufacturing Practice) manufacturing capabilities.
How much funding has Impact Biotech raised?
Impact Biotech has raised a total of $3M in funding. The most recent round on record is Grant.
Where is Impact Biotech headquartered?
Impact Biotech is headquartered in Tel Aviv, Israel.
When was Impact Biotech founded?
Impact Biotech was founded in 1996.
What industry does Impact Biotech operate in?
Impact Biotech operates in Life Sciences, Cancer, Therapeutics, Biotech, MedTech, HealthTech.
How many employees does Impact Biotech have?
Impact Biotech has approximately 42 people on record.